NCT01515228 - Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III) | Biotech Hunter

Enrollment

291

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions

Coronary Artery Disease

Interventions

DEVICE

Xience Prime

everolimus-eluting stent implantation

DEVICE

Cilotax stent

paclitaxel with cilostazol dual drug eluting stent implantation

Trial Locations (9)

Soon Chun Hyang University Hospital Cheonan, Cheonan

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

Chungnam National University Hospital, Daejeon

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Inje University Pusan Paik Hospital, Pusan

Asan Medical Center, Seoul

Ulsan University Hospital, Ulsan

All Listed Sponsors

collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

CHEOL WHAN LEE, MD, PhD.

OTHER